Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
6,786
archived clinical trials in
Dermatology

A Multicenter, Randomized, Placebo-Controlled, Double-Blind Study of SUN13834 in Adult Subjects With Atopic Dermatitis
A Multicenter, Randomized, Placebo-Controlled, Double-Blind Study of SUN13834 in Adult Subjects With Atopic Dermatitis
Status: Enrolling
Updated:  10/19/2015
Advanced Dermatology and Cosmetic Surgery
746
mi
from 43215
Ormond Beach, FL
A Multicenter, Randomized, Placebo-Controlled, Double-Blind Study of SUN13834 in Adult Subjects With Atopic Dermatitis
A Multicenter, Randomized, Placebo-Controlled, Double-Blind Study of SUN13834 in Adult Subjects With Atopic Dermatitis
Status: Enrolling
Updated: 10/19/2015
Advanced Dermatology and Cosmetic Surgery
746
mi
from 43215
Ormond Beach, FL
Click here to add this to my saved trials
A Multicenter, Randomized, Placebo-Controlled, Double-Blind Study of SUN13834 in Adult Subjects With Atopic Dermatitis
A Multicenter, Randomized, Placebo-Controlled, Double-Blind Study of SUN13834 in Adult Subjects With Atopic Dermatitis
Status: Enrolling
Updated:  10/19/2015
Stedman Clinical Trials
821
mi
from 43215
Tampa, FL
A Multicenter, Randomized, Placebo-Controlled, Double-Blind Study of SUN13834 in Adult Subjects With Atopic Dermatitis
A Multicenter, Randomized, Placebo-Controlled, Double-Blind Study of SUN13834 in Adult Subjects With Atopic Dermatitis
Status: Enrolling
Updated: 10/19/2015
Stedman Clinical Trials
821
mi
from 43215
Tampa, FL
Click here to add this to my saved trials
A Multicenter, Randomized, Placebo-Controlled, Double-Blind Study of SUN13834 in Adult Subjects With Atopic Dermatitis
A Multicenter, Randomized, Placebo-Controlled, Double-Blind Study of SUN13834 in Adult Subjects With Atopic Dermatitis
Status: Enrolling
Updated:  10/19/2015
Northwest Clinical Trials
1720
mi
from 43215
Boise, ID
A Multicenter, Randomized, Placebo-Controlled, Double-Blind Study of SUN13834 in Adult Subjects With Atopic Dermatitis
A Multicenter, Randomized, Placebo-Controlled, Double-Blind Study of SUN13834 in Adult Subjects With Atopic Dermatitis
Status: Enrolling
Updated: 10/19/2015
Northwest Clinical Trials
1720
mi
from 43215
Boise, ID
Click here to add this to my saved trials
A Multicenter, Randomized, Placebo-Controlled, Double-Blind Study of SUN13834 in Adult Subjects With Atopic Dermatitis
A Multicenter, Randomized, Placebo-Controlled, Double-Blind Study of SUN13834 in Adult Subjects With Atopic Dermatitis
Status: Enrolling
Updated:  10/19/2015
Deaconess Clinic Downtown-Research Institute
279
mi
from 43215
Evansville, IN
A Multicenter, Randomized, Placebo-Controlled, Double-Blind Study of SUN13834 in Adult Subjects With Atopic Dermatitis
A Multicenter, Randomized, Placebo-Controlled, Double-Blind Study of SUN13834 in Adult Subjects With Atopic Dermatitis
Status: Enrolling
Updated: 10/19/2015
Deaconess Clinic Downtown-Research Institute
279
mi
from 43215
Evansville, IN
Click here to add this to my saved trials
A Multicenter, Randomized, Placebo-Controlled, Double-Blind Study of SUN13834 in Adult Subjects With Atopic Dermatitis
A Multicenter, Randomized, Placebo-Controlled, Double-Blind Study of SUN13834 in Adult Subjects With Atopic Dermatitis
Status: Enrolling
Updated:  10/19/2015
DermResearch, PLLC
189
mi
from 43215
Louisville, KY
A Multicenter, Randomized, Placebo-Controlled, Double-Blind Study of SUN13834 in Adult Subjects With Atopic Dermatitis
A Multicenter, Randomized, Placebo-Controlled, Double-Blind Study of SUN13834 in Adult Subjects With Atopic Dermatitis
Status: Enrolling
Updated: 10/19/2015
DermResearch, PLLC
189
mi
from 43215
Louisville, KY
Click here to add this to my saved trials
A Multicenter, Randomized, Placebo-Controlled, Double-Blind Study of SUN13834 in Adult Subjects With Atopic Dermatitis
A Multicenter, Randomized, Placebo-Controlled, Double-Blind Study of SUN13834 in Adult Subjects With Atopic Dermatitis
Status: Enrolling
Updated:  10/19/2015
Michigan Center for Skin Care Research
182
mi
from 43215
Clinton Township, MI
A Multicenter, Randomized, Placebo-Controlled, Double-Blind Study of SUN13834 in Adult Subjects With Atopic Dermatitis
A Multicenter, Randomized, Placebo-Controlled, Double-Blind Study of SUN13834 in Adult Subjects With Atopic Dermatitis
Status: Enrolling
Updated: 10/19/2015
Michigan Center for Skin Care Research
182
mi
from 43215
Clinton Township, MI
Click here to add this to my saved trials
A Multicenter, Randomized, Placebo-Controlled, Double-Blind Study of SUN13834 in Adult Subjects With Atopic Dermatitis
A Multicenter, Randomized, Placebo-Controlled, Double-Blind Study of SUN13834 in Adult Subjects With Atopic Dermatitis
Status: Enrolling
Updated:  10/19/2015
Academic Dermatology
1331
mi
from 43215
Albuquerque, NM
A Multicenter, Randomized, Placebo-Controlled, Double-Blind Study of SUN13834 in Adult Subjects With Atopic Dermatitis
A Multicenter, Randomized, Placebo-Controlled, Double-Blind Study of SUN13834 in Adult Subjects With Atopic Dermatitis
Status: Enrolling
Updated: 10/19/2015
Academic Dermatology
1331
mi
from 43215
Albuquerque, NM
Click here to add this to my saved trials
A Multicenter, Randomized, Placebo-Controlled, Double-Blind Study of SUN13834 in Adult Subjects With Atopic Dermatitis
A Multicenter, Randomized, Placebo-Controlled, Double-Blind Study of SUN13834 in Adult Subjects With Atopic Dermatitis
Status: Enrolling
Updated:  10/19/2015
Derm Research Center of New York, Inc.
524
mi
from 43215
Stony Brook, NY
A Multicenter, Randomized, Placebo-Controlled, Double-Blind Study of SUN13834 in Adult Subjects With Atopic Dermatitis
A Multicenter, Randomized, Placebo-Controlled, Double-Blind Study of SUN13834 in Adult Subjects With Atopic Dermatitis
Status: Enrolling
Updated: 10/19/2015
Derm Research Center of New York, Inc.
524
mi
from 43215
Stony Brook, NY
Click here to add this to my saved trials
A Multicenter, Randomized, Placebo-Controlled, Double-Blind Study of SUN13834 in Adult Subjects With Atopic Dermatitis
A Multicenter, Randomized, Placebo-Controlled, Double-Blind Study of SUN13834 in Adult Subjects With Atopic Dermatitis
Status: Enrolling
Updated:  10/19/2015
Wake Research Associates, LLC
369
mi
from 43215
Raleigh, NC
A Multicenter, Randomized, Placebo-Controlled, Double-Blind Study of SUN13834 in Adult Subjects With Atopic Dermatitis
A Multicenter, Randomized, Placebo-Controlled, Double-Blind Study of SUN13834 in Adult Subjects With Atopic Dermatitis
Status: Enrolling
Updated: 10/19/2015
Wake Research Associates, LLC
369
mi
from 43215
Raleigh, NC
Click here to add this to my saved trials
A Multicenter, Randomized, Placebo-Controlled, Double-Blind Study of SUN13834 in Adult Subjects With Atopic Dermatitis
A Multicenter, Randomized, Placebo-Controlled, Double-Blind Study of SUN13834 in Adult Subjects With Atopic Dermatitis
Status: Enrolling
Updated:  10/19/2015
Wake Forest University Health Sciences - Dermatology Studies
306
mi
from 43215
Winston-Salem, NC
A Multicenter, Randomized, Placebo-Controlled, Double-Blind Study of SUN13834 in Adult Subjects With Atopic Dermatitis
A Multicenter, Randomized, Placebo-Controlled, Double-Blind Study of SUN13834 in Adult Subjects With Atopic Dermatitis
Status: Enrolling
Updated: 10/19/2015
Wake Forest University Health Sciences - Dermatology Studies
306
mi
from 43215
Winston-Salem, NC
Click here to add this to my saved trials
A Multicenter, Randomized, Placebo-Controlled, Double-Blind Study of SUN13834 in Adult Subjects With Atopic Dermatitis
A Multicenter, Randomized, Placebo-Controlled, Double-Blind Study of SUN13834 in Adult Subjects With Atopic Dermatitis
Status: Enrolling
Updated:  10/19/2015
Toledo Center for Clinical Research
125
mi
from 43215
Sylvania, OH
A Multicenter, Randomized, Placebo-Controlled, Double-Blind Study of SUN13834 in Adult Subjects With Atopic Dermatitis
A Multicenter, Randomized, Placebo-Controlled, Double-Blind Study of SUN13834 in Adult Subjects With Atopic Dermatitis
Status: Enrolling
Updated: 10/19/2015
Toledo Center for Clinical Research
125
mi
from 43215
Sylvania, OH
Click here to add this to my saved trials
A Multicenter, Randomized, Placebo-Controlled, Double-Blind Study of SUN13834 in Adult Subjects With Atopic Dermatitis
A Multicenter, Randomized, Placebo-Controlled, Double-Blind Study of SUN13834 in Adult Subjects With Atopic Dermatitis
Status: Enrolling
Updated:  10/19/2015
Oklahoma University Health Sciences Center, Dermatology Dept
848
mi
from 43215
Oklahoma City, OK
A Multicenter, Randomized, Placebo-Controlled, Double-Blind Study of SUN13834 in Adult Subjects With Atopic Dermatitis
A Multicenter, Randomized, Placebo-Controlled, Double-Blind Study of SUN13834 in Adult Subjects With Atopic Dermatitis
Status: Enrolling
Updated: 10/19/2015
Oklahoma University Health Sciences Center, Dermatology Dept
848
mi
from 43215
Oklahoma City, OK
Click here to add this to my saved trials
A Multicenter, Randomized, Placebo-Controlled, Double-Blind Study of SUN13834 in Adult Subjects With Atopic Dermatitis
A Multicenter, Randomized, Placebo-Controlled, Double-Blind Study of SUN13834 in Adult Subjects With Atopic Dermatitis
Status: Enrolling
Updated:  10/19/2015
Paddington Testing Co., Inc.
415
mi
from 43215
Philadelphia, PA
A Multicenter, Randomized, Placebo-Controlled, Double-Blind Study of SUN13834 in Adult Subjects With Atopic Dermatitis
A Multicenter, Randomized, Placebo-Controlled, Double-Blind Study of SUN13834 in Adult Subjects With Atopic Dermatitis
Status: Enrolling
Updated: 10/19/2015
Paddington Testing Co., Inc.
415
mi
from 43215
Philadelphia, PA
Click here to add this to my saved trials
A Multicenter, Randomized, Placebo-Controlled, Double-Blind Study of SUN13834 in Adult Subjects With Atopic Dermatitis
A Multicenter, Randomized, Placebo-Controlled, Double-Blind Study of SUN13834 in Adult Subjects With Atopic Dermatitis
Status: Enrolling
Updated:  10/19/2015
Clinical Partners, LLC
614
mi
from 43215
Johnston, RI
A Multicenter, Randomized, Placebo-Controlled, Double-Blind Study of SUN13834 in Adult Subjects With Atopic Dermatitis
A Multicenter, Randomized, Placebo-Controlled, Double-Blind Study of SUN13834 in Adult Subjects With Atopic Dermatitis
Status: Enrolling
Updated: 10/19/2015
Clinical Partners, LLC
614
mi
from 43215
Johnston, RI
Click here to add this to my saved trials
A Multicenter, Randomized, Placebo-Controlled, Double-Blind Study of SUN13834 in Adult Subjects With Atopic Dermatitis
A Multicenter, Randomized, Placebo-Controlled, Double-Blind Study of SUN13834 in Adult Subjects With Atopic Dermatitis
Status: Enrolling
Updated:  10/19/2015
Radiant Research
350
mi
from 43215
Greer, SC
A Multicenter, Randomized, Placebo-Controlled, Double-Blind Study of SUN13834 in Adult Subjects With Atopic Dermatitis
A Multicenter, Randomized, Placebo-Controlled, Double-Blind Study of SUN13834 in Adult Subjects With Atopic Dermatitis
Status: Enrolling
Updated: 10/19/2015
Radiant Research
350
mi
from 43215
Greer, SC
Click here to add this to my saved trials
A Multicenter, Randomized, Placebo-Controlled, Double-Blind Study of SUN13834 in Adult Subjects With Atopic Dermatitis
A Multicenter, Randomized, Placebo-Controlled, Double-Blind Study of SUN13834 in Adult Subjects With Atopic Dermatitis
Status: Enrolling
Updated:  10/19/2015
J&S Studies
988
mi
from 43215
College Station, TX
A Multicenter, Randomized, Placebo-Controlled, Double-Blind Study of SUN13834 in Adult Subjects With Atopic Dermatitis
A Multicenter, Randomized, Placebo-Controlled, Double-Blind Study of SUN13834 in Adult Subjects With Atopic Dermatitis
Status: Enrolling
Updated: 10/19/2015
J&S Studies
988
mi
from 43215
College Station, TX
Click here to add this to my saved trials
A Multicenter, Randomized, Placebo-Controlled, Double-Blind Study of SUN13834 in Adult Subjects With Atopic Dermatitis
A Multicenter, Randomized, Placebo-Controlled, Double-Blind Study of SUN13834 in Adult Subjects With Atopic Dermatitis
Status: Enrolling
Updated:  10/19/2015
Baylor Research Institute of Dermatology Department
909
mi
from 43215
Dallas, TX
A Multicenter, Randomized, Placebo-Controlled, Double-Blind Study of SUN13834 in Adult Subjects With Atopic Dermatitis
A Multicenter, Randomized, Placebo-Controlled, Double-Blind Study of SUN13834 in Adult Subjects With Atopic Dermatitis
Status: Enrolling
Updated: 10/19/2015
Baylor Research Institute of Dermatology Department
909
mi
from 43215
Dallas, TX
Click here to add this to my saved trials
A Multicenter, Randomized, Placebo-Controlled, Double-Blind Study of SUN13834 in Adult Subjects With Atopic Dermatitis
A Multicenter, Randomized, Placebo-Controlled, Double-Blind Study of SUN13834 in Adult Subjects With Atopic Dermatitis
Status: Enrolling
Updated:  10/19/2015
Dermatology Associates of San Antonio
1138
mi
from 43215
San Antonio, TX
A Multicenter, Randomized, Placebo-Controlled, Double-Blind Study of SUN13834 in Adult Subjects With Atopic Dermatitis
A Multicenter, Randomized, Placebo-Controlled, Double-Blind Study of SUN13834 in Adult Subjects With Atopic Dermatitis
Status: Enrolling
Updated: 10/19/2015
Dermatology Associates of San Antonio
1138
mi
from 43215
San Antonio, TX
Click here to add this to my saved trials
A Multicenter, Randomized, Placebo-Controlled, Double-Blind Study of SUN13834 in Adult Subjects With Atopic Dermatitis
A Multicenter, Randomized, Placebo-Controlled, Double-Blind Study of SUN13834 in Adult Subjects With Atopic Dermatitis
Status: Enrolling
Updated:  10/19/2015
Intermountain Clinical Research
1515
mi
from 43215
Draper, UT
A Multicenter, Randomized, Placebo-Controlled, Double-Blind Study of SUN13834 in Adult Subjects With Atopic Dermatitis
A Multicenter, Randomized, Placebo-Controlled, Double-Blind Study of SUN13834 in Adult Subjects With Atopic Dermatitis
Status: Enrolling
Updated: 10/19/2015
Intermountain Clinical Research
1515
mi
from 43215
Draper, UT
Click here to add this to my saved trials
A Multicenter, Randomized, Placebo-Controlled, Double-Blind Study of SUN13834 in Adult Subjects With Atopic Dermatitis
A Multicenter, Randomized, Placebo-Controlled, Double-Blind Study of SUN13834 in Adult Subjects With Atopic Dermatitis
Status: Enrolling
Updated:  10/19/2015
Commonwealth Clinical Research Specialists, Inc.
342
mi
from 43215
Richmond, VA
A Multicenter, Randomized, Placebo-Controlled, Double-Blind Study of SUN13834 in Adult Subjects With Atopic Dermatitis
A Multicenter, Randomized, Placebo-Controlled, Double-Blind Study of SUN13834 in Adult Subjects With Atopic Dermatitis
Status: Enrolling
Updated: 10/19/2015
Commonwealth Clinical Research Specialists, Inc.
342
mi
from 43215
Richmond, VA
Click here to add this to my saved trials
A Multicenter, Randomized, Placebo-Controlled, Double-Blind Study of SUN13834 in Adult Subjects With Atopic Dermatitis
A Multicenter, Randomized, Placebo-Controlled, Double-Blind Study of SUN13834 in Adult Subjects With Atopic Dermatitis
Status: Enrolling
Updated:  10/19/2015
Premier Clinical Research
1779
mi
from 43215
Spokane, WA
A Multicenter, Randomized, Placebo-Controlled, Double-Blind Study of SUN13834 in Adult Subjects With Atopic Dermatitis
A Multicenter, Randomized, Placebo-Controlled, Double-Blind Study of SUN13834 in Adult Subjects With Atopic Dermatitis
Status: Enrolling
Updated: 10/19/2015
Premier Clinical Research
1779
mi
from 43215
Spokane, WA
Click here to add this to my saved trials
The Lipid Profile of the Skin Surface in Acne
The Lipid Profile of the Skin Surface in Acne
Status: Enrolling
Updated:  10/31/2015
Dermatology Research Area
2057
mi
from 43215
Davis, CA
The Lipid Profile of the Skin Surface in Acne
The Lipid Profile of the Skin Surface in Acne
Status: Enrolling
Updated: 10/31/2015
Dermatology Research Area
2057
mi
from 43215
Davis, CA
Click here to add this to my saved trials
The Lipid Profile of the Skin Surface in Acne
The Lipid Profile of the Skin Surface in Acne
Status: Enrolling
Updated:  10/31/2015
UC Davis Department of Dermatology
2042
mi
from 43215
Sacramento, CA
The Lipid Profile of the Skin Surface in Acne
The Lipid Profile of the Skin Surface in Acne
Status: Enrolling
Updated: 10/31/2015
UC Davis Department of Dermatology
2042
mi
from 43215
Sacramento, CA
Click here to add this to my saved trials
Infliximab to Improve Retention of the Boston Keratoprosthesis in Patients After Stevens Johnson Syndrome/ Toxic Epidermal Necrolysis (SJS/TENS)
Infliximab Therapy to Improve Retention of the Boston Keratoprosthesis in Patients After Stevens Johnson Syndrome/ Toxic Epidermal Necrolysis
Status: Enrolling
Updated:  11/3/2015
Massachusetts Eye & Ear Infirmary
643
mi
from 43215
Boston, MA
Infliximab to Improve Retention of the Boston Keratoprosthesis in Patients After Stevens Johnson Syndrome/ Toxic Epidermal Necrolysis (SJS/TENS)
Infliximab Therapy to Improve Retention of the Boston Keratoprosthesis in Patients After Stevens Johnson Syndrome/ Toxic Epidermal Necrolysis
Status: Enrolling
Updated: 11/3/2015
Massachusetts Eye & Ear Infirmary
643
mi
from 43215
Boston, MA
Click here to add this to my saved trials
The Effect of Diluted Sodium Hypochlorite Solution and Moisturizers on Skin Barrier Function in Atopic Dermatitis
The Effect of Diluted Sodium Hypochlorite Solution and Moisturizers on Skin Barrier Function in Atopic Dermatitis
Status: Enrolling
Updated:  11/3/2015
UC Davis Department of Dermatology
2042
mi
from 43215
Sacramento, CA
The Effect of Diluted Sodium Hypochlorite Solution and Moisturizers on Skin Barrier Function in Atopic Dermatitis
The Effect of Diluted Sodium Hypochlorite Solution and Moisturizers on Skin Barrier Function in Atopic Dermatitis
Status: Enrolling
Updated: 11/3/2015
UC Davis Department of Dermatology
2042
mi
from 43215
Sacramento, CA
Click here to add this to my saved trials
Study of the Effect of Low Level Laser Light on Hair Growth on the Female Human Scalp
An Evaluation of the Effect of the Erchonia ML Scanner (MLS) on the Treatment of Androgenic Alopecia in Females
Status: Enrolling
Updated:  11/7/2015
Advanced Gynecology Specialists of Georgia
445
mi
from 43215
Evans, GA
Study of the Effect of Low Level Laser Light on Hair Growth on the Female Human Scalp
An Evaluation of the Effect of the Erchonia ML Scanner (MLS) on the Treatment of Androgenic Alopecia in Females
Status: Enrolling
Updated: 11/7/2015
Advanced Gynecology Specialists of Georgia
445
mi
from 43215
Evans, GA
Click here to add this to my saved trials
A Single Dose Phase I Exploratory Study in Healthy Volunteers With GSK2894512 Cream
Skin Residency Study of Topically Applied GSK2894512 Cream in Healthy Volunteers
Status: Enrolling
Updated:  11/9/2015
GSK Investigational Site
274
mi
from 43215
Urbana, IL
A Single Dose Phase I Exploratory Study in Healthy Volunteers With GSK2894512 Cream
Skin Residency Study of Topically Applied GSK2894512 Cream in Healthy Volunteers
Status: Enrolling
Updated: 11/9/2015
GSK Investigational Site
274
mi
from 43215
Urbana, IL
Click here to add this to my saved trials
A Phase 2 Study of CIM331 for Atopic Dermatitis Patients
A PHASE II, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, MULTIPLE-DOSE STUDY TO EVALUATE THE SAFETY, TOLERABILITY, AND EFFICACY OF CIM331 IN ATOPIC DERMATITIS PATIENTS WHO ARE INADEQUATELY CONTROLLED BY OR INTOLERANT TO TOPICAL THERAPY
Status: Enrolling
Updated:  11/12/2015
Clinical Research Facility
166
mi
from 43215
Indianapolis, IN
A Phase 2 Study of CIM331 for Atopic Dermatitis Patients
A PHASE II, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, MULTIPLE-DOSE STUDY TO EVALUATE THE SAFETY, TOLERABILITY, AND EFFICACY OF CIM331 IN ATOPIC DERMATITIS PATIENTS WHO ARE INADEQUATELY CONTROLLED BY OR INTOLERANT TO TOPICAL THERAPY
Status: Enrolling
Updated: 11/12/2015
Clinical Research Facility
166
mi
from 43215
Indianapolis, IN
Click here to add this to my saved trials
A Phase 2 Study of CIM331 for Atopic Dermatitis Patients
A PHASE II, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, MULTIPLE-DOSE STUDY TO EVALUATE THE SAFETY, TOLERABILITY, AND EFFICACY OF CIM331 IN ATOPIC DERMATITIS PATIENTS WHO ARE INADEQUATELY CONTROLLED BY OR INTOLERANT TO TOPICAL THERAPY
Status: Enrolling
Updated:  11/12/2015
Clinical Research Facility
1951
mi
from 43215
San Diego, CA
A Phase 2 Study of CIM331 for Atopic Dermatitis Patients
A PHASE II, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, MULTIPLE-DOSE STUDY TO EVALUATE THE SAFETY, TOLERABILITY, AND EFFICACY OF CIM331 IN ATOPIC DERMATITIS PATIENTS WHO ARE INADEQUATELY CONTROLLED BY OR INTOLERANT TO TOPICAL THERAPY
Status: Enrolling
Updated: 11/12/2015
Clinical Research Facility
1951
mi
from 43215
San Diego, CA
Click here to add this to my saved trials
A Phase 2 Study of CIM331 for Atopic Dermatitis Patients
A PHASE II, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, MULTIPLE-DOSE STUDY TO EVALUATE THE SAFETY, TOLERABILITY, AND EFFICACY OF CIM331 IN ATOPIC DERMATITIS PATIENTS WHO ARE INADEQUATELY CONTROLLED BY OR INTOLERANT TO TOPICAL THERAPY
Status: Enrolling
Updated:  11/12/2015
Clinical Research Facility
993
mi
from 43215
Miami, FL
A Phase 2 Study of CIM331 for Atopic Dermatitis Patients
A PHASE II, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, MULTIPLE-DOSE STUDY TO EVALUATE THE SAFETY, TOLERABILITY, AND EFFICACY OF CIM331 IN ATOPIC DERMATITIS PATIENTS WHO ARE INADEQUATELY CONTROLLED BY OR INTOLERANT TO TOPICAL THERAPY
Status: Enrolling
Updated: 11/12/2015
Clinical Research Facility
993
mi
from 43215
Miami, FL
Click here to add this to my saved trials
A Phase 2 Study of CIM331 for Atopic Dermatitis Patients
A PHASE II, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, MULTIPLE-DOSE STUDY TO EVALUATE THE SAFETY, TOLERABILITY, AND EFFICACY OF CIM331 IN ATOPIC DERMATITIS PATIENTS WHO ARE INADEQUATELY CONTROLLED BY OR INTOLERANT TO TOPICAL THERAPY
Status: Enrolling
Updated:  11/12/2015
Clinical Research Facility
412
mi
from 43215
Alpharetta, GA
A Phase 2 Study of CIM331 for Atopic Dermatitis Patients
A PHASE II, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, MULTIPLE-DOSE STUDY TO EVALUATE THE SAFETY, TOLERABILITY, AND EFFICACY OF CIM331 IN ATOPIC DERMATITIS PATIENTS WHO ARE INADEQUATELY CONTROLLED BY OR INTOLERANT TO TOPICAL THERAPY
Status: Enrolling
Updated: 11/12/2015
Clinical Research Facility
412
mi
from 43215
Alpharetta, GA
Click here to add this to my saved trials
A Phase 2 Study of CIM331 for Atopic Dermatitis Patients
A PHASE II, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, MULTIPLE-DOSE STUDY TO EVALUATE THE SAFETY, TOLERABILITY, AND EFFICACY OF CIM331 IN ATOPIC DERMATITIS PATIENTS WHO ARE INADEQUATELY CONTROLLED BY OR INTOLERANT TO TOPICAL THERAPY
Status: Enrolling
Updated:  11/12/2015
Clinical Research Facility
297
mi
from 43215
Arlington Heights, IL
A Phase 2 Study of CIM331 for Atopic Dermatitis Patients
A PHASE II, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, MULTIPLE-DOSE STUDY TO EVALUATE THE SAFETY, TOLERABILITY, AND EFFICACY OF CIM331 IN ATOPIC DERMATITIS PATIENTS WHO ARE INADEQUATELY CONTROLLED BY OR INTOLERANT TO TOPICAL THERAPY
Status: Enrolling
Updated: 11/12/2015
Clinical Research Facility
297
mi
from 43215
Arlington Heights, IL
Click here to add this to my saved trials
A Phase 2 Study of CIM331 for Atopic Dermatitis Patients
A PHASE II, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, MULTIPLE-DOSE STUDY TO EVALUATE THE SAFETY, TOLERABILITY, AND EFFICACY OF CIM331 IN ATOPIC DERMATITIS PATIENTS WHO ARE INADEQUATELY CONTROLLED BY OR INTOLERANT TO TOPICAL THERAPY
Status: Enrolling
Updated:  11/12/2015
Clinical Research Facility
274
mi
from 43215
Chicago, IL
A Phase 2 Study of CIM331 for Atopic Dermatitis Patients
A PHASE II, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, MULTIPLE-DOSE STUDY TO EVALUATE THE SAFETY, TOLERABILITY, AND EFFICACY OF CIM331 IN ATOPIC DERMATITIS PATIENTS WHO ARE INADEQUATELY CONTROLLED BY OR INTOLERANT TO TOPICAL THERAPY
Status: Enrolling
Updated: 11/12/2015
Clinical Research Facility
274
mi
from 43215
Chicago, IL
Click here to add this to my saved trials
A Phase 2 Study of CIM331 for Atopic Dermatitis Patients
A PHASE II, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, MULTIPLE-DOSE STUDY TO EVALUATE THE SAFETY, TOLERABILITY, AND EFFICACY OF CIM331 IN ATOPIC DERMATITIS PATIENTS WHO ARE INADEQUATELY CONTROLLED BY OR INTOLERANT TO TOPICAL THERAPY
Status: Enrolling
Updated:  11/12/2015
Clinical Research Facility
422
mi
from 43215
Norfolk, VA
A Phase 2 Study of CIM331 for Atopic Dermatitis Patients
A PHASE II, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, MULTIPLE-DOSE STUDY TO EVALUATE THE SAFETY, TOLERABILITY, AND EFFICACY OF CIM331 IN ATOPIC DERMATITIS PATIENTS WHO ARE INADEQUATELY CONTROLLED BY OR INTOLERANT TO TOPICAL THERAPY
Status: Enrolling
Updated: 11/12/2015
Clinical Research Facility
422
mi
from 43215
Norfolk, VA
Click here to add this to my saved trials
A Phase 2 Study of CIM331 for Atopic Dermatitis Patients
A PHASE II, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, MULTIPLE-DOSE STUDY TO EVALUATE THE SAFETY, TOLERABILITY, AND EFFICACY OF CIM331 IN ATOPIC DERMATITIS PATIENTS WHO ARE INADEQUATELY CONTROLLED BY OR INTOLERANT TO TOPICAL THERAPY
Status: Enrolling
Updated:  11/12/2015
Clinical Research Facility
188
mi
from 43215
Louisville, KY
A Phase 2 Study of CIM331 for Atopic Dermatitis Patients
A PHASE II, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, MULTIPLE-DOSE STUDY TO EVALUATE THE SAFETY, TOLERABILITY, AND EFFICACY OF CIM331 IN ATOPIC DERMATITIS PATIENTS WHO ARE INADEQUATELY CONTROLLED BY OR INTOLERANT TO TOPICAL THERAPY
Status: Enrolling
Updated: 11/12/2015
Clinical Research Facility
188
mi
from 43215
Louisville, KY
Click here to add this to my saved trials
A Phase 2 Study of CIM331 for Atopic Dermatitis Patients
A PHASE II, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, MULTIPLE-DOSE STUDY TO EVALUATE THE SAFETY, TOLERABILITY, AND EFFICACY OF CIM331 IN ATOPIC DERMATITIS PATIENTS WHO ARE INADEQUATELY CONTROLLED BY OR INTOLERANT TO TOPICAL THERAPY
Status: Enrolling
Updated:  11/12/2015
Clinical Research Facility
188
mi
from 43215
Louisville, KY
A Phase 2 Study of CIM331 for Atopic Dermatitis Patients
A PHASE II, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, MULTIPLE-DOSE STUDY TO EVALUATE THE SAFETY, TOLERABILITY, AND EFFICACY OF CIM331 IN ATOPIC DERMATITIS PATIENTS WHO ARE INADEQUATELY CONTROLLED BY OR INTOLERANT TO TOPICAL THERAPY
Status: Enrolling
Updated: 11/12/2015
Clinical Research Facility
188
mi
from 43215
Louisville, KY
Click here to add this to my saved trials
A Phase 2 Study of CIM331 for Atopic Dermatitis Patients
A PHASE II, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, MULTIPLE-DOSE STUDY TO EVALUATE THE SAFETY, TOLERABILITY, AND EFFICACY OF CIM331 IN ATOPIC DERMATITIS PATIENTS WHO ARE INADEQUATELY CONTROLLED BY OR INTOLERANT TO TOPICAL THERAPY
Status: Enrolling
Updated:  11/12/2015
Clinical Research Facility
253
mi
from 43215
Bay City, MI
A Phase 2 Study of CIM331 for Atopic Dermatitis Patients
A PHASE II, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, MULTIPLE-DOSE STUDY TO EVALUATE THE SAFETY, TOLERABILITY, AND EFFICACY OF CIM331 IN ATOPIC DERMATITIS PATIENTS WHO ARE INADEQUATELY CONTROLLED BY OR INTOLERANT TO TOPICAL THERAPY
Status: Enrolling
Updated: 11/12/2015
Clinical Research Facility
253
mi
from 43215
Bay City, MI
Click here to add this to my saved trials
A Phase 2 Study of CIM331 for Atopic Dermatitis Patients
A PHASE II, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, MULTIPLE-DOSE STUDY TO EVALUATE THE SAFETY, TOLERABILITY, AND EFFICACY OF CIM331 IN ATOPIC DERMATITIS PATIENTS WHO ARE INADEQUATELY CONTROLLED BY OR INTOLERANT TO TOPICAL THERAPY
Status: Enrolling
Updated:  11/12/2015
Clinical Research Facility
481
mi
from 43215
New York, NY
A Phase 2 Study of CIM331 for Atopic Dermatitis Patients
A PHASE II, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, MULTIPLE-DOSE STUDY TO EVALUATE THE SAFETY, TOLERABILITY, AND EFFICACY OF CIM331 IN ATOPIC DERMATITIS PATIENTS WHO ARE INADEQUATELY CONTROLLED BY OR INTOLERANT TO TOPICAL THERAPY
Status: Enrolling
Updated: 11/12/2015
Clinical Research Facility
481
mi
from 43215
New York, NY
Click here to add this to my saved trials
A Phase 2 Study of CIM331 for Atopic Dermatitis Patients
A PHASE II, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, MULTIPLE-DOSE STUDY TO EVALUATE THE SAFETY, TOLERABILITY, AND EFFICACY OF CIM331 IN ATOPIC DERMATITIS PATIENTS WHO ARE INADEQUATELY CONTROLLED BY OR INTOLERANT TO TOPICAL THERAPY
Status: Enrolling
Updated:  11/12/2015
Clinical Research Facility
350
mi
from 43215
Charlotte, NC
A Phase 2 Study of CIM331 for Atopic Dermatitis Patients
A PHASE II, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, MULTIPLE-DOSE STUDY TO EVALUATE THE SAFETY, TOLERABILITY, AND EFFICACY OF CIM331 IN ATOPIC DERMATITIS PATIENTS WHO ARE INADEQUATELY CONTROLLED BY OR INTOLERANT TO TOPICAL THERAPY
Status: Enrolling
Updated: 11/12/2015
Clinical Research Facility
350
mi
from 43215
Charlotte, NC
Click here to add this to my saved trials
A Phase 2 Study of CIM331 for Atopic Dermatitis Patients
A PHASE II, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, MULTIPLE-DOSE STUDY TO EVALUATE THE SAFETY, TOLERABILITY, AND EFFICACY OF CIM331 IN ATOPIC DERMATITIS PATIENTS WHO ARE INADEQUATELY CONTROLLED BY OR INTOLERANT TO TOPICAL THERAPY
Status: Enrolling
Updated:  11/12/2015
Clinical Research Facility
127
mi
from 43215
Cleveland, OH
A Phase 2 Study of CIM331 for Atopic Dermatitis Patients
A PHASE II, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, MULTIPLE-DOSE STUDY TO EVALUATE THE SAFETY, TOLERABILITY, AND EFFICACY OF CIM331 IN ATOPIC DERMATITIS PATIENTS WHO ARE INADEQUATELY CONTROLLED BY OR INTOLERANT TO TOPICAL THERAPY
Status: Enrolling
Updated: 11/12/2015
Clinical Research Facility
127
mi
from 43215
Cleveland, OH
Click here to add this to my saved trials
A Phase 2 Study of CIM331 for Atopic Dermatitis Patients
A PHASE II, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, MULTIPLE-DOSE STUDY TO EVALUATE THE SAFETY, TOLERABILITY, AND EFFICACY OF CIM331 IN ATOPIC DERMATITIS PATIENTS WHO ARE INADEQUATELY CONTROLLED BY OR INTOLERANT TO TOPICAL THERAPY
Status: Enrolling
Updated:  11/12/2015
Clinical Research Facility
2026
mi
from 43215
Portland, OR
A Phase 2 Study of CIM331 for Atopic Dermatitis Patients
A PHASE II, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, MULTIPLE-DOSE STUDY TO EVALUATE THE SAFETY, TOLERABILITY, AND EFFICACY OF CIM331 IN ATOPIC DERMATITIS PATIENTS WHO ARE INADEQUATELY CONTROLLED BY OR INTOLERANT TO TOPICAL THERAPY
Status: Enrolling
Updated: 11/12/2015
Clinical Research Facility
2026
mi
from 43215
Portland, OR
Click here to add this to my saved trials
A Phase 2 Study of CIM331 for Atopic Dermatitis Patients
A PHASE II, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, MULTIPLE-DOSE STUDY TO EVALUATE THE SAFETY, TOLERABILITY, AND EFFICACY OF CIM331 IN ATOPIC DERMATITIS PATIENTS WHO ARE INADEQUATELY CONTROLLED BY OR INTOLERANT TO TOPICAL THERAPY
Status: Enrolling
Updated:  11/12/2015
Clinical Research Facility
527
mi
from 43215
Charleston, SC
A Phase 2 Study of CIM331 for Atopic Dermatitis Patients
A PHASE II, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, MULTIPLE-DOSE STUDY TO EVALUATE THE SAFETY, TOLERABILITY, AND EFFICACY OF CIM331 IN ATOPIC DERMATITIS PATIENTS WHO ARE INADEQUATELY CONTROLLED BY OR INTOLERANT TO TOPICAL THERAPY
Status: Enrolling
Updated: 11/12/2015
Clinical Research Facility
527
mi
from 43215
Charleston, SC
Click here to add this to my saved trials
A Phase 2 Study of CIM331 for Atopic Dermatitis Patients
A PHASE II, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, MULTIPLE-DOSE STUDY TO EVALUATE THE SAFETY, TOLERABILITY, AND EFFICACY OF CIM331 IN ATOPIC DERMATITIS PATIENTS WHO ARE INADEQUATELY CONTROLLED BY OR INTOLERANT TO TOPICAL THERAPY
Status: Enrolling
Updated:  11/12/2015
Clinical Research Facility
527
mi
from 43215
Charleston, SC
A Phase 2 Study of CIM331 for Atopic Dermatitis Patients
A PHASE II, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, MULTIPLE-DOSE STUDY TO EVALUATE THE SAFETY, TOLERABILITY, AND EFFICACY OF CIM331 IN ATOPIC DERMATITIS PATIENTS WHO ARE INADEQUATELY CONTROLLED BY OR INTOLERANT TO TOPICAL THERAPY
Status: Enrolling
Updated: 11/12/2015
Clinical Research Facility
527
mi
from 43215
Charleston, SC
Click here to add this to my saved trials
A Phase 2 Study of CIM331 for Atopic Dermatitis Patients
A PHASE II, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, MULTIPLE-DOSE STUDY TO EVALUATE THE SAFETY, TOLERABILITY, AND EFFICACY OF CIM331 IN ATOPIC DERMATITIS PATIENTS WHO ARE INADEQUATELY CONTROLLED BY OR INTOLERANT TO TOPICAL THERAPY
Status: Enrolling
Updated:  11/12/2015
Clinical Research Facility
987
mi
from 43215
College Station, TX
A Phase 2 Study of CIM331 for Atopic Dermatitis Patients
A PHASE II, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, MULTIPLE-DOSE STUDY TO EVALUATE THE SAFETY, TOLERABILITY, AND EFFICACY OF CIM331 IN ATOPIC DERMATITIS PATIENTS WHO ARE INADEQUATELY CONTROLLED BY OR INTOLERANT TO TOPICAL THERAPY
Status: Enrolling
Updated: 11/12/2015
Clinical Research Facility
987
mi
from 43215
College Station, TX
Click here to add this to my saved trials
A Phase 2 Study of CIM331 for Atopic Dermatitis Patients
A PHASE II, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, MULTIPLE-DOSE STUDY TO EVALUATE THE SAFETY, TOLERABILITY, AND EFFICACY OF CIM331 IN ATOPIC DERMATITIS PATIENTS WHO ARE INADEQUATELY CONTROLLED BY OR INTOLERANT TO TOPICAL THERAPY
Status: Enrolling
Updated:  11/12/2015
Clinical Research Facility
462
mi
from 43215
Anniston, AL
A Phase 2 Study of CIM331 for Atopic Dermatitis Patients
A PHASE II, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, MULTIPLE-DOSE STUDY TO EVALUATE THE SAFETY, TOLERABILITY, AND EFFICACY OF CIM331 IN ATOPIC DERMATITIS PATIENTS WHO ARE INADEQUATELY CONTROLLED BY OR INTOLERANT TO TOPICAL THERAPY
Status: Enrolling
Updated: 11/12/2015
Clinical Research Facility
462
mi
from 43215
Anniston, AL
Click here to add this to my saved trials
The CARRA Registry
The CARRA Registry
Status: Enrolling
Updated:  11/16/2015
Duke Clinical Research Institute
352
mi
from 43215
Durham, NC
The CARRA Registry
The CARRA Registry
Status: Enrolling
Updated: 11/16/2015
Duke Clinical Research Institute
352
mi
from 43215
Durham, NC
Click here to add this to my saved trials
A Long-Term Safety and Efficacy Study of AGN-199201 in Patients With Persistent Erythema Associated With Rosacea
Status: Enrolling
Updated:  11/17/2015
Clinical Research Facility
2026
mi
from 43215
Portland, OR
A Long-Term Safety and Efficacy Study of AGN-199201 in Patients With Persistent Erythema Associated With Rosacea
Status: Enrolling
Updated: 11/17/2015
Clinical Research Facility
2026
mi
from 43215
Portland, OR
Click here to add this to my saved trials
Evaluation of an Herbal-Based De-Pigmenting System
A Clinical Usage Study to Evaluate the Safety and Efficacy of an Herbal-Based De-Pigmenting System
Status: Enrolling
Updated:  11/17/2015
Sadick Research Group
480
mi
from 43215
New York, NY
Evaluation of an Herbal-Based De-Pigmenting System
A Clinical Usage Study to Evaluate the Safety and Efficacy of an Herbal-Based De-Pigmenting System
Status: Enrolling
Updated: 11/17/2015
Sadick Research Group
480
mi
from 43215
New York, NY
Click here to add this to my saved trials
Clinical Evaluation of T.R.U.E. TEST® : Safety and Efficacy
Clinical Evaluation of T.R.U.E. TEST® Panel 3.2 Allergens: Gold Sodium Thiosulfate, Hydrocortisone-17-Butyrate, Methyldibromoglutaronitrile, Bacitracin, Parthenolide, Disperse Blue 106, and Bronopol
Status: Enrolling
Updated:  11/18/2015
River City Dermatology
623
mi
from 43215
Little Rock, AR
Clinical Evaluation of T.R.U.E. TEST® : Safety and Efficacy
Clinical Evaluation of T.R.U.E. TEST® Panel 3.2 Allergens: Gold Sodium Thiosulfate, Hydrocortisone-17-Butyrate, Methyldibromoglutaronitrile, Bacitracin, Parthenolide, Disperse Blue 106, and Bronopol
Status: Enrolling
Updated: 11/18/2015
River City Dermatology
623
mi
from 43215
Little Rock, AR
Click here to add this to my saved trials
Clinical Evaluation of T.R.U.E. TEST® : Safety and Efficacy
Clinical Evaluation of T.R.U.E. TEST® Panel 3.2 Allergens: Gold Sodium Thiosulfate, Hydrocortisone-17-Butyrate, Methyldibromoglutaronitrile, Bacitracin, Parthenolide, Disperse Blue 106, and Bronopol
Status: Enrolling
Updated:  11/18/2015
American Dermatology Associates
626
mi
from 43215
Shawnee, KA
Clinical Evaluation of T.R.U.E. TEST® : Safety and Efficacy
Clinical Evaluation of T.R.U.E. TEST® Panel 3.2 Allergens: Gold Sodium Thiosulfate, Hydrocortisone-17-Butyrate, Methyldibromoglutaronitrile, Bacitracin, Parthenolide, Disperse Blue 106, and Bronopol
Status: Enrolling
Updated: 11/18/2015
American Dermatology Associates
626
mi
from 43215
Shawnee, KA
Click here to add this to my saved trials